Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012-2022 in Hangzhou, China: implication for public health strategies

被引:0
作者
Li, Qingchun [1 ]
Wu, Yifei [1 ]
Cheng, Qinglin [1 ]
Lu, Min [1 ]
Huang, Yinyan [1 ]
Bai, Xuexin [1 ]
Jia, Qingjun [1 ]
Fang, Zijian [1 ]
Ai, Liyun [1 ]
Jiang, Nan [1 ]
Lao, Qiufeng [2 ]
Xie, Li [1 ]
Chen, Junfang [1 ]
机构
[1] Hangzhou Hlth Supervis Inst, Hangzhou Ctr Dis Control & Prevent, 568 Mingshi Rd, Hangzhou City 310021, Peoples R China
[2] Guangxi Med Univ, Liuzhou Peoples Hosp, Liuzhou, Peoples R China
关键词
MDR; TB; Ecdemic; Prevalence; Hangzhou; China; TRANSMISSION; MANAGEMENT; DIAGNOSIS; COVID-19;
D O I
10.1186/s12889-024-20273-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundTo assess the prevalence and epidemic pattern of multidrug-resistant tuberculosis in Hangzhou City, Zhejiang Province, China during 2012-2022.MethodsAll the tuberculosis cases undergoing drug susceptibility testing during 2012-2022 were included in this study. De-identified information was extracted from the electronic database Tuberculosis Information Management System for analysis of drug resistance prevalence in Hangzhou and ecdemic multidrug-resistant tuberculosis which originated from other regions. Chi-square tests were used to compare drug resistance rates between different groups, while Chi-square tests for trend were used to evaluate the change of drug resistance rates over the years of 2012-2022. The sources and destinations of ecdemic multidrug-resistant tuberculosis were illustrated using a Sankey diagram.ResultsOf 21,127 cases included in this study, 1119 (5.3%) were multidrug-resistant tuberculosis. A significant decline in multidrug-resistant tuberculosis rates was observed during 2012-2022. There was a significant difference in multidrug-resistant tuberculosis rates among immigrant population and local residents in Hangzhou City. Of 1119 multidrug-resistant tuberculosis cases, 515(46%) were ecdemic multidrug-resistant tuberculosis cases, of which 277(53.8%) were from other parts of Zhejiang Province and 238(46.2%) were from other provinces in China. Anhui, Jiangxi and Sichuan were among top three provinces which were the source of ecdemic multidrug-resistant tuberculosis cases. Three districts including Xiaoshan, Shangcheng and Linping districts had the most cases in Hangzhou. The proportion of ecdemic multidrug-resistant tuberculosis cases in Binjiang, Xiaoshan, Qiantang and Linping districtalso exceeded 30% of total cases.ConclusionsMultidrug-resistant tuberculosis prevalence has been declining in Hangzhou. Migrant population contributed to a significant potion of cases in Hangzhou. Interventions should be tailed to local and migrant residents.
引用
收藏
页数:7
相关论文
共 35 条
[1]   COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia [J].
Caren, Gabriella J. ;
Iskandar, Deni ;
Pitaloka, Dian A. E. ;
Abdulah, Rizky ;
Suwantika, Auliya A. .
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2022, 15 :175-183
[2]  
Chen Yu, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2018-225794
[3]   Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST) [J].
Choi, Hongjo ;
Mok, Jeongha ;
Kang, Young Ae ;
Jeong, Dawoon ;
Kang, Hee-Yeon ;
Kim, Hee Jin ;
Kim, Hee-Sun ;
Jeon, Doosoo .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (05)
[4]   The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis [J].
Dheda, Keertan ;
Gumbo, Tawanda ;
Maartens, Gary ;
Dooley, Kelly E. ;
Murray, Megan ;
Furin, Jennifer ;
Nardell, Edward A. ;
Warren, Robin M. ;
Esmail, Aliasgar ;
London, Leslie ;
Lessem, Erica ;
Limberis, Jason ;
Theron, Grant ;
McNerney, Ruth ;
Niemann, Stefan ;
Dowdy, David ;
Van Rie, Annelies ;
Pasipanodya, Jotam G. ;
Rodrigues, Camilla ;
Clark, Taane G. ;
Sirgel, Frik A. ;
Schaaf, H. Simon ;
Chang, Kwok Chiu ;
Lange, Christoph ;
Nahid, Payam ;
Fourie, Bernard ;
Ndjeka, Norbert ;
Nunn, Andrew ;
Migliori, G. B. ;
Udwadia, Zarir F. ;
Horsburgh, C. Robert, Jr. ;
Churchyard, Gavin J. ;
Menzies, Dick ;
Hesseling, Anneke C. ;
Seddon, James A. ;
Low, Marcus ;
Keshavjee, Salmaan ;
Nuermberger, Eric ;
McIlleron, Helen ;
Fennelly, Kevin P. ;
Jindani, Amina ;
Jaramillo, Ernesto ;
Padayatchi, Nesri ;
Barry, Clifton E., III .
LANCET RESPIRATORY MEDICINE, 2019, 7 (09) :820-826
[5]   Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis [J].
Ding, Peipei ;
Li, Xiaowen ;
Jia, Zhongwei ;
Lu, Zuhong .
BMC INFECTIOUS DISEASES, 2017, 17
[6]  
Flores-Valdez MA, 2022, Biomedicines, V10
[7]   Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status [J].
Ge, E. ;
Li, D. ;
Luo, M. ;
Tsui, K. W. S. ;
Waye, M. M. Y. ;
Shen, X. ;
Wei, X. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (12) :1462-+
[8]   Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: A systematic review and meta-analysis of the prevalence, determinants and treatment outcome [J].
Girum T. ;
Muktar E. ;
Lentiro K. ;
Wondiye H. ;
Shewangizaw M. .
Tropical Diseases, Travel Medicine and Vaccines, 4 (1)
[9]   Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis [J].
Goyal, Vishal ;
Kadam, Vijay ;
Narang, Prashant ;
Singh, Vikram .
BMC PUBLIC HEALTH, 2017, 17
[10]  
Hangzhou Municipal Bureau of Statistics, 2023, HANGZHOU STAT YB